PREVALANCE OF BACTERIAL ISOLATES GROWTH FROM GASTROENTERITIS AMONG PATIENTS IN THREE DIFFERENT CLINICS WITHIN UMUAHIA

  • 0 Review(s)

Product Category: Projects

Product Code: 00009075

No of Pages: 54

No of Chapters: 1-5

File Format: Microsoft Word

Price :

₦3000

  • $

ABSTRACT

Gastroenteritis is an infection of the gut (intestines) with viruses, bacteria, or other microbes. You may develop diarrhea, sickness (vomiting), tummy (abdominal) pain and other symptoms. This study evaluated the incidence of gastroenteritis in three (3) different clinics in Umuahia. A total of 48 faecal specimens were collected using sterile plastic bottles with air-tight screw cap tops from 3 different hospitals within Umuahia. Salmonella sp, Shigella sp, Escherichia coli and Staphylococcus aureus with a percentage occurrence of 37.5%, 29.2%, 20.8%, and 12.5% respectively, were found to cause gastroenteritis .It was observed that Abia state specialist has the highest rate of bacterial load with a percentage distribution of 22(45.8%) followed by Amara-Jane hospital with percentage distribution of 17(35.4%), whereas, Mouau clinic has the least bacterial load with a percentage distribution of 9(18.8%). Out of 48 samples, 4 clinical Bacteria were isolated and tested for antibiotics susceptibility, Ciprofloxacin was the most effective antimicrobial agent with 45 representing (93.8%) susceptibility followed by Gentamicin with 40 representing (83.3%), Levofloxacin37(77.1%), Ampiclox 22(45.8%) ,Norfloxacin 18(37.5%) and Amoxil17(35.4%), Streptomycin 13(27.1%),  whereas Chloramphenicol  has the least percentage susceptibility of 6 representing (12.5%). It was observed that the bacterial isolates showed high rate of resistance Chloramphenicol with the percentage resistance of 42(87.5%), followed by Erythromycin 39(81.3%), Rifampicin 36(75.0%), then Streptomycin 35(72.9%), Amoxil 31(64.6%), Norfloxacin 30(62.5%) and moderately resistant to Ampiclox26(45.8%), whereas Ciprofloxacin  has the least percentage resistance of 3 representing (6.3%). This emphasizes the need for continuous evaluation of the quality of common antibiotics, prudent drug prescription and judicious use of these antibiotics in gastroenteritis management.





TABLE OF CONTENTS


Title Page                                                                                                                                 i

Certification                                                                                                                           ii

Dedication                                                                                                                              iii

Acknowledgement                                                                                                                  iv

Table of Contents                                                                                                                   v

List of Tables                                                                                                                          viii

Abstract                                                                                                                                  ix

CHAPTER ONE

1.0       Introduction                                                                                                                1

1.1       Aims and Objectives                                                                                                  3

CHAPTER TWO

2.0       Literature Review                                                                                                       5

2.1       Bacterial Gastroenteritis                                                                                             5

2.1.1    Epidemiology                                                                                                             5

2.1.2    Pathophysiology                                                                                                         6

2.1.3    Medical Examination                                                                                                 7

2.2       Bacterial Pathogens Associated With Gastroenteritis                                                            8

2.2.1    AeromonasSpecies                                                                                                      8

2.2.2    Bacillus cereus                                                                                                           9

2.2.3    Campylobacter Species                                                                                              10

2.2.4    Clostridium difficile                                                                                                   12

2.2.5    Clostridium perfringens                                                                                             13

2.2.6    Escherichia coli                                                                                                          14

2.2.7    Listeria monocytogenes                                                                                              15

2.2.8    Plesiomonasshigelloides                                                                                            16

2.2.9    Salmonella Species                                                                                                     17

2.2.10  Shigella Species                                                                                                          17

2.2.11  Staphylococcus aureus                                                                                               19

2.2.12  Vibrio and Vibrio-Like Species                                                                                  20

2.3       Gastroenteritis in Nigeria                                                                                     21

CHAPTER THREE

3.0       Materials and Method                                                                                                 23

3.1       Collection of Samples                                                                                                23

3.2       Sterilization of Materials                                                                                            23

3.3       Preparation of Culture Media                                                                                     23

3.4       Inoculation and Isolation                                                                                            23

3.5       Purification of Isolates                                                                                               24

3.6       Identification of the Isolates                                                                                       24

3.7       Gram Staining                                                                                                            24

3.8       Biochemical Test                                                                                                        25

3.8.1    Catalase Test                                                                                                               25

3.8.2    Indole Test                                                                                                                  25

3.8.3    Citrate Utilization Test                                                                                               25

3.8.4    Hydrogen Sulphide (H2S) Production Test                                                                25

3.8.5    Motility, Indole, Urease (MIU)                                                                                  26

3.8.6    Coagulase Test                                                                                                           26

3.8.7    Oxidase Test                                                                                                               27

3.9       Antibiotic Susceptibility Testing                                                                                27

CHAPTER FOUR

4.0       Results                                                          28

4.1       Morphological identification, Biochemical Identification, Gram Reaction

and Sugar Utilization Profile of bacterial isolates from Stool samples            28

4.2       Percentage occurrence of bacterial isolates from the stool samples                28

4.3       Distribution of Bacterial Isolates from the stool samples                                28

4.4       Antibiotics Sensitivity Pattern of the Bacterial Isolates from the stool

Samples                                                                                                                      28

4.5       Antibiotics Resistance Pattern of the Bacterial Isolates from the stool

Samples                                                                                                                      29

4.6       Overall Antibiotic Susceptibility and resistance pattern of all the isolates

            from the stool specimens.                                                                                29

 

CHAPTER FIVE

5.0       Discussion, Conclusion and Recommendation                                              36

5.1       Discussion                                                                                                     36

5.2       Conclusion                                                                                                    38

5.3       Recommendations                                            38

 

References                                                                              39

Appendix I : Pictures Of  Plates                                  43

 

 

 

 

  

 

LIST OF TABLES

TABLE

TITLE

PAGE

4.1

Morphological identification, Biochemical Identification, Gram Reaction and Sugar Utilization Profile of bacterial isolates from the stool samples

30

4.2

Percentage occurrence of bacterial isolates from the stool samples

31

4.3

Distribution of Bacteria Isolates from the stool samples

32

4.4

Antibiotics Sensitivity Pattern of the Bacterial Isolates from the stool Samples

33

4.5

Antibiotics Resistance Pattern of the Bacterial Isolates from the stool samples

34

4.6

Overall Antibiotic Susceptibility and resistance pattern of all the isolates from the stool specimens

35

 

 

 

 

 

 

CHAPTER ONE


1.0       INTRODUCTION

           Enteric diseases is a common illness and accounts for substantial proportion of consultation by doctors and health care centers. It is a major cause of morbidity and mortality in poor and developing countries. Several studies have been conducted with a view to establish the importance of different enteric bacteria in the etiology of acute diarrhea. However, the relative incidence of the pathogens varies from place to place and also in same geographic region from time to time. This present investigation was a hospital based study comprising of patients suffering from gastroenteritis. It includes the microbiological examination of bacteria which is considered to be the etiological agent of enteric diseases in patients.The enteric diseases are caused by the members of family Enterobacteriaceae and Vibrionaceae. These pathogens are named as enteric pathogens which belong to the genera that initiate infection by invading the intestinal epithelium. The enteric pathogens belonging to the family Enterobacteriaceae are predominantly facultative anaerobic bacteria flora of large intestine of human beings. These are generally non-spore forming, non acid fast and gram negative straight or curved rod. These organisms are classified based on their mode of use of lactose in MacConkey agar medium, the most popular medium for the isolation of fecal bacilli. The enteric disease causing members of family Enterobacteriaceae are E.coli, Shigella, Salmonella, Proteus, Klebsiella pneumoniae, Citrobacter freundii, Enterobacteraerogenes. The pathogens belonging to family Vibrionaceae are also responsible for enteric disease .The organism Vibrio cholera causing cholera is characterized by Gram negative curved rod that actively motile. The vibrio colonies can be identified by the use of selective media like TCBS, MacConkey and blood agar. Socio-economically backward classes of population frequently receive the epidemics of diarrhea disease, accounting high morbidity and mortality among the people. The mortality rate due to diarrheal infection is a robust indicator of the overall health status of population. As per the SRS (sample registration system) data infant mortality was 91% in 2001 & 87% in 2002 due to diarrhea disease. The CRD (crude death rate) in Orissa in 2001 &2002 was 10.4 and 9.8% respectively. Data on severe diarrhea and gastroenteritis in children was 14.2% (as per Registration general of India, 1998 -2000).As per available report under the Orissa multi disease surveillance system 144672 diarrhea cases are registered in 2003 & 1,56,872 diarrhea cases in 2002. 15-40 % of all death among the children aged < 5years are due to diarrhea disease. The united nation said that no. of suspected cholera cases in Zimbabwe since August 2008 has claimed above 12600 with 570 deaths because of lack of water treatment, Brocken sewage pipe. As on 26thNov 2008 more than 3000 people have died from cholera. As it is being mentioned earlier world 25% death is caused by bacteria every year. It can be eradicated by developing sophisticated medical facilities and proper hygienic condition. Chemotherapeutic agent like antibiotics kills or stops the growth of susceptible microorganism. These drug include beta-lactame, aminoglycosidesand, fluoroquinolones, Tetracyclines, chloramphenicol, sulfonamide, these are effective against enterococci. But in recent year strain develops resistant to antibiotic has become international problems. Plants derived substances have become matter of great interest owing to their versatile application (Baris et al., 2006). Medicinal plants are the richest bio-resources of drug of traditional system of medicine, modern medicine, food supplement and folk medicine, pharmaceutical intermediate and chemical entities of synthetic drug. A number of interesting outcome have been found with the use of mixture of natural product to treat disease, most notably the synergic effect of polypharmacological application of plant extract (Gibbons, 2003).The herbal extract obtained from Aeglemarmelos, Menthaspicata and Ocimum sanctum can be used to treat enteric disease. Piperitone obtained from plant essential oil enhances the bactericidal activity of nitrofurantoin and furazolidone against bacteria belonging to family Enterobacteriaceae. Menthaspicata & Menthapiperita contain 40.12 % & 20.32% carvone respectively. Pure carvone and piperitone equally increases the bactericidal activity of nitrofurantoin. Ethanolics leaf extract are more effective towards the bacterial species. It contains shahidine an unstable oxazoline which is active against Gram +ve / Gram –ve both. Ethanolic leaf extract of Ocimum sanctum contain biologically active compound like urosolic acid, apigenin and luteolin which are responsible for antimicrobial activity. There are long term studies continuing, looking at long term effect of enteric pathogens, therefore there is a need of screening of new compound having antimicrobial activity against pathogens.


1.1       AIMS AND OBJECTIVES

The aim of this study is to determine the prevalence of gastroenteritis among patients from 3 different hospitals within Umuahia.

The objectives are;

1.     To isolate and identify the bacteria isolates present in the stool samples obtained from the 3 different hospitals in Umuahia.

2.     To determine the percentage occurrence of the bacterial isolates from the various stool samples.

3.     To carry out the antimicrobial sensitivity testing of the various isolates.

 

Click “DOWNLOAD NOW” below to get the complete Projects

FOR QUICK HELP CHAT WITH US NOW!

+(234) 0814 780 1594

Buyers has the right to create dispute within seven (7) days of purchase for 100% refund request when you experience issue with the file received. 

Dispute can only be created when you receive a corrupt file, a wrong file or irregularities in the table of contents and content of the file you received. 

ProjectShelve.com shall either provide the appropriate file within 48hrs or send refund excluding your bank transaction charges. Term and Conditions are applied.

Buyers are expected to confirm that the material you are paying for is available on our website ProjectShelve.com and you have selected the right material, you have also gone through the preliminary pages and it interests you before payment. DO NOT MAKE BANK PAYMENT IF YOUR TOPIC IS NOT ON THE WEBSITE.

In case of payment for a material not available on ProjectShelve.com, the management of ProjectShelve.com has the right to keep your money until you send a topic that is available on our website within 48 hours.

You cannot change topic after receiving material of the topic you ordered and paid for.

Ratings & Reviews

0.0

No Review Found.


To Review


To Comment